Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophila

被引：10

作者：

Carbon, C ^{[1
]}

Nusrat, R ^{[1
]}

机构：

[1] Aventis, Dept Antiinfect & Pulm Clin Dev, Bridgewater, NJ 08807 USA

来源：

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2004年 / 23卷 / 08期

关键词：

D O I：

10.1007/s10096-004-1152-2

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：650 / 652

页数：3

共 17 条

[1]

Balfour JAB, 2001, DRUGS, V61, P815

[2] Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia [J].

Carbon, C ;

Moola, S ;

Velancsics, I ;

Leroy, B ;

Rangaraju, M ;

Decosta, P .

CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) :691-703

[3] Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults [J].

Dunbar, LM ;

Hassman, J ;

Tellier, G .

CLINICAL THERAPEUTICS, 2004, 26 (01) :48-62

[4] In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia [J].

Edelstein, PH ;

Edelstein, MAC .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (01) :90-95

[5] A prediction rule to identify low-risk patients with community-acquired pneumonia [J].

Fine, MJ ;

Auble, TE ;

Yealy, DM ;

Hanusa, BH ;

Weissfeld, LA ;

Singer, DE ;

Coley, CM ;

Marrie, TJ ;

Kapoor, WN .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (04) :243-250

[6]

FOGARTY C, 2004, 14 EUR C CLIN MICR I

[7]

FOGARTY C, 2001, 41 INT C ANT AG CHEM

[8]

GLEASON PP, 2002, PHARMACOTHERAPY S1, V22, P2

[9] Telithromycin in the treatment of community-acquired pneumonia: a pooled analysis [J].

Hagberg, L ;

Carbon, C ;

Van Rensburg, DJ ;

Fogarty, C ;

Dunbar, L ;

Pullman, J .

RESPIRATORY MEDICINE, 2003, 97 (06) :625-633

[10] Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia [J].

Hagberg, L ;

Torres, A ;

van Rensburg, D ;

Leroy, B ;

Rangaraju, M ;

Ruuth, E .

INFECTION, 2002, 30 (06) :378-386

← 1 2 →